- Home
- CNTA vs STRA Comparison
CNTA vs STRA Comparison
Compare CNTA & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- STRA
- Stock Information
- Founded
- CNTA 2020
- STRA 2017
- Country
- CNTA United Kingdom
- STRA United States
- Employees
- CNTA N/A
- STRA N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- STRA Other Consumer Services
- Sector
- CNTA Health Care
- STRA Real Estate
- Exchange
- CNTA Nasdaq
- STRA Nasdaq
- Market Cap
- CNTA 2.3B
- STRA 2.1B
- IPO Year
- CNTA 2021
- STRA 1996
- Fundamental
- Price
- CNTA $22.74
- STRA $79.87
- Analyst Decision
- CNTA Strong Buy
- STRA Strong Buy
- Analyst Count
- CNTA 8
- STRA 3
- Target Price
- CNTA $31.29
- STRA $104.33
- AVG Volume (30 Days)
- CNTA 995.9K
- STRA 151.3K
- Earning Date
- CNTA 11-11-2025
- STRA 11-06-2025
- Dividend Yield
- CNTA N/A
- STRA 3.02%
- EPS Growth
- CNTA N/A
- STRA N/A
- EPS
- CNTA N/A
- STRA 4.81
- Revenue
- CNTA $15,000,000.00
- STRA $1,242,475,000.00
- Revenue This Year
- CNTA N/A
- STRA $5.58
- Revenue Next Year
- CNTA N/A
- STRA $4.11
- P/E Ratio
- CNTA N/A
- STRA $16.55
- Revenue Growth
- CNTA 118.88
- STRA 4.31
- 52 Week Low
- CNTA $9.60
- STRA $72.25
- 52 Week High
- CNTA $24.57
- STRA $104.51
- Technical
- Relative Strength Index (RSI)
- CNTA 56.30
- STRA 42.45
- Support Level
- CNTA $21.78
- STRA $78.08
- Resistance Level
- CNTA $23.08
- STRA $81.11
- Average True Range (ATR)
- CNTA 1.00
- STRA 1.80
- MACD
- CNTA -0.28
- STRA -0.58
- Stochastic Oscillator
- CNTA 35.84
- STRA 21.60
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About STRA Strategic Education Inc.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.